Quick Answer
Core Laboratories Inc. /DE/ reported Operating Income Loss of $56.47 million for the year ending 2025.
- Core Laboratories Inc. /DE/ showed a decrease of -3.6% in Operating Income Loss from 2024 to 2025.
- This data is from Core Laboratories Inc. /DE/'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $11.65 million | Q3 2022: $14.65 million | Q1 2023: $6.48 million | Q2 2023: $18.91 million | Q3 2023: $14.67 million | Q1 2024: $8.57 million | Q2 2024: $16.01 million | Q3 2024: $19.80 million | Q1 2025: $4.42 million | Q2 2025: $15.29 million | Q3 2025: $20.93 million.
- Over the full 5 years of available data (2021 to 2025), Core Laboratories Inc. /DE/'s Operating Income Loss has grown by 24.8%.
- Historical annual values: Fiscal year 2025: $56.47 million | Fiscal year 2024: $58.56 million | Fiscal year 2023: $54.64 million | Fiscal year 2022: $41.52 million | Fiscal year 2021: $45.26 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: